Every record from Medutest · page 12
Fast turnaround and the widest compound acceptance, at unit mass resolution rather than high resolution. Measured offset against the reference laboratory is +0.065 pp on 517 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-021259 | Cagrilintide | BCH | BCH-2509-A6666 | 2025-Q4 | 99.72 | 6.16 | 95.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020875 | CJC-1295 (no DAC) | CPC | CPC-2509-L1903 | 2025-Q4 | 97.53 | 6.48 | 101.9 | Supplier-supplied | 2 | FAIL |
| AX-2025-018997 | CJC-1295 (no DAC) | FGP | FGP-2508-C2848 | 2025-Q3 | 99.44 | 5.31 | 93.5 | Supplier-supplied | 0 | PASS |
| AX-2025-019341 | Liraglutide | TFC | TFC-2510-C7425 | 2025-Q4 | 98.46 | 4.31 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020007 | Ipamorelin | ERP | ERP-2505-U6755 | 2025-Q4 | 99.74 | 3.89 | 95.6 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-018799 | AOD-9604 | QSC | QSC-2508-B8479 | 2025-Q3 | 99.21 | 3.63 | 97.8 | Supplier-supplied | 0 | PASS |
| AX-2025-021256 | Cagrilintide | BCH | BCH-2509-A6666 | 2025-Q4 | 99.04 | 6.47 | 92.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019967 | BPC-157 | SWB | SWB-2511-N6092 | 2025-Q4 | 99.53 | 6.42 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020580 | PEG-MGF | SSA | SSA-2505-U6896 | 2025-Q4 | 95.90 | 2.63 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019116 | BPC-157 | JEEP | JEEP-2507-V4206 | 2025-Q3 | 99.74 | 4.71 | 92.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019950 | 5-Amino-1MQ | SWB | SWB-2507-E6159 | 2025-Q3 | 99.75 | 5.78 | 96.6 | Supplier-supplied | 2 | FAIL |
| AX-2025-020884 | BPC-157 | CPC | CPC-2503-T1811 | 2025-Q3 | 99.72 | 4.66 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020600 | Semaglutide | SSA | SSA-2508-Y6894 | 2025-Q3 | 98.51 | 5.01 | 105.9 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019605 | TB-500 | Homopeptide | HOMO-2507-L1962 | 2025-Q4 | 99.27 | 4.50 | 89.6 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-019937 | Mazdutide | SWB | SWB-2505-Y5355 | 2025-Q4 | 98.58 | 3.51 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019890 | Selank | SWB | SWB-2511-C5170 | 2025-Q4 | 98.95 | 9.19 | 107.4 | Buyer-sourced | 0 | FAIL |
| AX-2025-021130 | Semaglutide | WXT | WXT-2509-A5382 | 2025-Q4 | 99.06 | 6.06 | 101.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019831 | Semaglutide | SWB | SWB-2504-Y4284 | 2025-Q3 | 99.47 | 2.74 | 101.6 | Supplier-supplied | 0 | PASS |
| AX-2025-020418 | Melanotan II | KP | KP-2508-J4716 | 2025-Q3 | 98.40 | 6.66 | 96.7 | Supplier-supplied | 1 | FAIL |
| AX-2025-018858 | Desmopressin | QSC | QSC-2505-N8999 | 2025-Q3 | 99.93 | 4.92 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020903 | Semaglutide | CPC | CPC-2504-G2724 | 2025-Q3 | 98.33 | 5.01 | 96.4 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-020516 | GHK-Cu | KP | KP-2502-C5740 | 2025-Q3 | 98.71 | 3.58 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020996 | IGF-1 LR3 | WXT | WXT-2508-G4016 | 2025-Q3 | 97.66 | 3.81 | 96.0 | Supplier-supplied | 0 | PASS |
| AX-2025-021289 | Tirzepatide | BCH | BCH-2508-A7737 | 2025-Q3 | 98.35 | 4.92 | 97.3 | Buyer-sourced | 2 | MARGINAL |
| AX-2025-020637 | Gonadorelin | SSA | SSA-2504-M8130 | 2025-Q3 | 99.93 | 4.68 | — | Supplier-supplied | 3 | FAIL |
| AX-2025-019698 | TB-500 | HJ | HJ-2502-U2908 | 2025-Q3 | 99.41 | 3.44 | 103.3 | Buyer-sourced | 4 | MARGINAL |
| AX-2025-019344 | Retatrutide | TFC | TFC-2503-X7298 | 2025-Q3 | 98.68 | 6.16 | 106.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020384 | MGF | MKM | MKM-2508-S3601 | 2025-Q3 | 98.30 | 3.25 | 91.9 | Supplier-supplied | 1 | FAIL |
| AX-2025-019985 | Semaglutide | ERP | ERP-2508-S6110 | 2025-Q3 | 99.71 | 3.04 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019740 | Ipamorelin | HJ | HJ-2504-X2985 | 2025-Q3 | 99.47 | 6.99 | 91.9 | Supplier-supplied | 0 | PASS |
| AX-2025-021002 | IGF-1 LR3 | WXT | WXT-2508-G4016 | 2025-Q3 | 97.43 | 4.36 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019468 | Retatrutide | Homopeptide | HOMO-2508-U9007 | 2025-Q3 | 98.65 | 5.94 | 100.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018683 | Dihexa | QYB | QYB-2503-Y6694 | 2025-Q3 | 99.93 | 7.57 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020359 | Liraglutide | MKM | MKM-2508-P3929 | 2025-Q3 | 97.84 | 7.40 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020020 | MOTS-c | ERP | ERP-2508-M7270 | 2025-Q3 | 98.77 | 1.89 | 107.0 | Supplier-supplied | 0 | PASS |
| AX-2025-019735 | Ipamorelin | HJ | HJ-2504-X2985 | 2025-Q3 | 99.93 | 6.11 | 97.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021264 | Pemvidutide | BCH | BCH-2506-G6608 | 2025-Q3 | 97.48 | 5.15 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020298 | Ipamorelin | MKM | MKM-2504-N3425 | 2025-Q3 | 98.78 | 5.20 | — | Buyer-sourced | 2 | FAIL |
| AX-2025-019750 | Semaglutide | HJ | HJ-2507-Y3362 | 2025-Q3 | 98.76 | 3.12 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019320 | Retatrutide | TFC | TFC-2508-H7325 | 2025-Q3 | 97.30 | 3.52 | — | Supplier-supplied | 1 | MARGINAL |